Source: Eur Respir J 2013; 42: 547-550
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Albanna Amr S., Bachmann Kenneth, White Donald, Valiquette Chantal, Menzies Dick. Serum lipids as biomarkers for therapeutic monitoring of latent tuberculosis infection. Eur Respir J 2013; 42: 547-550

Member's Comments

No comment yet.

Related content which might interest you: Urinary neopterin levels discriminate active from latent mycobacterium tuberculosis infection Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis Year: 2011 Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection Source: Eur Respir J 2006; 28: Suppl. 50, 164s Year: 2006 Dynamics of inflammation biomarkers in drug sensitive tuberculosis and pneumonia Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020 Serum Procalcitonin for diagnosing and monitoring response in pleural infection Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019 The use of interferon-γ-based blood tests for the detection of latent tuberculosis infection Source: Eur Respir J 2006; 28: 1-3 Year: 2006 The identification of tuberculosis biomarkers in human urine samples Source: Eur Respir J 2014; 43: 1719-1729 Year: 2014 Evaluation of IP-10 in blood serum for TB diagnosis in patients with late-stage HIV infection Source: International Congress 2019 – Tuberculosis: diagnosis and scores Year: 2019 Capacities of blood serum lipoarabinomannan in the diagnosis of tuberculosis at a late stage of HIV infection Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018 Antibody and host inflammatory biomarker combinations as diagnostic tools for TB disease Source: International Congress 2017 – Update on TB: latest news Year: 2017 The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection Source: Eur Respir J 2015; 45: 569-571 Year: 2015 The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection Source: Eur Respir J 2015; 45: 571-574 Year: 2015 Serum concentration of cytokines before and during treatment in patients with active tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 10s Year: 2002 Evaluation of new biomarkers for laboratory diagnosis of tuberculosis Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018 Is neopterin concentration predictive in latent tuberculosis infection in health workers? Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I Year: 2008 Usefulness of serum procalcitonin levels in pulmonary tuberculosis Source: Eur Respir J 2011; 37: 371 Year: 2011 Impact of anti tuberculosis therapy in plasma zinc status in childhood tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 455s Year: 2005 The specificity of interferon-γ-based blood tests in the identification of latent tuberculosis infection Source: Eur Respir J 2006; 28: 1283 Year: 2006 Rapid diagnosis of tuberculosis using ex vivo host biomarkers in sputum Source: Eur Respir J 2014; 44: 254-257 Year: 2014 Serum cytokines level can differentiate active pulmonary tuberculosis from latent TB Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013 Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016